CARA - Cara Therapeutics EPS beats by $0.24 beats on revenue November, 09 2020 04:04 PM Cara Therapeutics Inc. Cara Therapeutics (CARA): Q3 GAAP EPS of -$0.35 beats by $0.24.Revenue of $9.27M (+60.1% Y/Y) beats by $4.5M.Press Release For further details see: Cara Therapeutics EPS beats by $0.24, beats on revenue